市場調査レポート
商品コード
1433456
多毛症治療の世界市場:2023-2030年Global Hirsutism Treatment Market 2023-2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
多毛症治療の世界市場:2023-2030年 |
出版日: 2024年01月13日
発行: Orion Market Research
ページ情報: 英文 100 Pages
納期: 2~3営業日
|
世界の多毛症治療市場は、予測期間(2024-2031年)中にCAGR 7.2%というかなりのCAGRで成長すると予測されています。この市場の成長は、女性の間で多毛症の有病率が増加していることに起因しています。米国家庭医学会によると、多毛症は女性の約8.0%が罹患しており、米国では年間6億米ドルを超える経済的負担が推定されています。ムダ毛に伴う美容的・心理的問題や多嚢胞性卵巣症候群の有病率の増加は、予測期間中の市場成長を促進すると予測される主な要因です。さらに、スレッディング、ワックス、プラッキング、ブリーチなどの従来の脱毛方法は、その優れた長期的な結果のために、レーザー脱毛に大きく取って代わられています。2022年6月にJournal of Clinical and Aesthetic Dermatologyに掲載された論文によると、レーザー技術の発展により、レーザーがムダ毛を取り除く方法として好まれるようになったことが確認されています。このように、技術の継続的な改善と人口の間でのレーザー治療の採用の増加は、予測期間中に多毛症治療の成長を促進すると予想されます。
個人の外見に対する関心が高まり、スキンケアへの支出が増加していることが、このセグメントの成長に寄与しています。顔の毛の量やタイプは女性によって異なります。Clinique Matriceが発表した記事によると、女性は顎の外側の角と上唇に薄い産毛が生えているのが一般的です。この自然な顔の毛は、ピーチ・ファズと呼ばれています。欧州諸国(イタリアとギリシャを含む)とインドのサブコンテンツの女性は、世界の他の地域の女性よりも余分な顔の毛を持っている傾向があります。
世界の多毛症治療市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域)、アジア太平洋地域(インド、中国、日本、韓国、その他アジア地域)、世界のその他の地域(中東とアフリカ、ラテンアメリカ)を含む地域に基づいてさらにセグメント化されます。このうち、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予測されています。多毛症治療に対する需要の増加、老人人口の増加、パーソナルケア支出の増加、脱毛治療の増加などがアジア太平洋の多毛症治療市場を牽引しています。
予測期間中、北米が多毛症治療市場で突出したシェアを占めると予想されます。同地域の市場シェアに寄与する重要な要因としては、多毛症患者の増加、ライフスタイルの変化、消費者の消費力の向上などが挙げられます。NIHによると、多毛症は最も一般的な内分泌疾患であり、米国では女性の10.0%近くが罹患しています。根本的な原因にもかかわらず、多毛症は大きな精神的苦痛や心理的苦悩を引き起こす可能性があります。さらに、多毛症の治療を行うクリニックの増加により、この地域の市場成長が促進されています。 2020年2月、医学部ウェブマスターのSu Hee Kim医学部助教授(内分泌学のフェローシップ・トレーニングを受けている)は、ミッドライフ・ヘルス・センターで新しいPCOSクリニックを開始しました。このクリニックでは、メタボリックの問題、PCOSに関連した多毛症、特に減量のための医学的支援を必要とするPCOSの女性のためのケアを提供しました。
Global Hirsutism Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Medications, and Procedures), By Application, (Upper Lip, Chin, Chest, Arms, Others), by End-use (Hospitals, Dermatology Clinics, and Aesthetic Centers), Forecast Period (2024-2031)
The global hirsutism treatment market is anticipated to grow at a considerable CAGR of 7.2% during the forecast period (2024-2031). The growth of this market is attributed to the increasing prevalence of hirsutism among women. According to the American Academy of Family Physicians, hirsutism affects around 8.0% of women, and it is associated with an estimated economic burden surpassing $600 million annually in the US. Cosmetic and psychological problems associated with unwanted hair and the increasing prevalence of polycystic ovary syndrome are major factors projected to fuel market growth during the forecast period. Further, traditional hair removal methods such as threading, waxing, plucking, and bleaching have largely been replaced by laser hair removal owing to their superior long-term results. According to an article published in the Journal of Clinical and Aesthetic Dermatology in June 2022, it has been observed that lasers are now the preferred method for getting rid of unwanted hair because of developments in laser technology. Thus, continuous improvements in technology and increasing adoption of laser treatments among the population are anticipated to propel the growth of hirsutism treatment during the forecast period.
The global hirsutism treatment market is segmented by treatment type, application, and end-use. Based on the treatment type, the market is sub-segmented into medications and procedures. Based on the application, the market is sub-segmented into upper lip, chin, chest, arms, and others. Where others include the neck and lower back. Further, based on end-use, the market is sub-segmented into hospitals, dermatology clinics, and aesthetic centers. Among the end-use, the dermatology clinics, and aesthetic centers sub-segment is anticipated to hold the largest market share during the forecast period. The large share of this segment is credited to lower costs, higher efficiency, and availability.
The rising concerns about appearance among individuals, and rising expenditure on skin care, attributing to the segmental growth. Facial hair varies in volume and type in women. As per the article published by Clinique Matrice, it is common for women to have light facial hair on the exterior corners of the jawline and upper lip. This natural facial hair is beneficial termed peach fuzz. Women from European countries (including Italy and Greece) and the Indian sub-content tend to have extra facial hair than women in other parts of the world.
The global hirsutism treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to grow at the highest CAGR over the forecast period. The growing demand for hirsutism treatment, the increasing geriatric population, the rising personal care expenditure, and increasing treatment for hair removal treatment driving the hirsutism treatment market in the Asia-Pacific.
North America is expected to hold a prominent share in the Hirsutism Treatment market during the forecast period. The significant factors contributing to the regional market share include the increasing number of hirsutism cases, changing lifestyles, and the increased spending power of consumers. According to the NIH, hirsutism is the most common endocrine disorder affecting nearly 10.0% of women in the US. Despite the underlying cause, hirsutism has the potential to cause significant emotional distress and psychological distress. Additionally, the increasing number of clinics for the treatment of hirsutism boosts the market growth in the region. In February 2020, the School of Medicine Webmaster, Dr. Su Hee Kim, Assistant Professor in Internal Medicine with fellowship training in Endocrinology, started a new PCOS clinic at the Midlife Health Center. This clinic offered care for women with metabolic issues, hirsutism related to PCOS, and especially women with PCOS requiring medical help with weight loss.
The major companies serving the hirsutism treatment market include Alma Lasers Ltd, Cynosure Inc., Lumenis Inc., Nisim Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in October 2022, Endymed Ltd. received FDA approval for the marketing and sales of Pure Laser, a new hair removal device in the US. This launch helped the company to improve the variety of its aesthetic offerings to both the Company's partners and clients.